H. Kumada

A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis

K. Chayama, A. Tsubota, K. Ikeda, 1993, Hepatology.

Hepatocellular carcinoma metastasis to the brain mimicking primary pituitary tumor around the sella turcica

K. Ikeda, Yuya Seko, Y. Kawamura, 2013, Clinical Journal of Gastroenterology.

Effectiveness of combination therapy of splenectomy and long‐term interferon in patients with hepatitis C virus‐related cirrhosis and thrombocytopenia

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

Quantitative analysis of hepatitis C virus RNA by competitive nested polymerase chain reaction

K. Chayama, A. Tsubota, K. Ikeda, 1993 .

LBA34 Primary results from the phase III LEAP-002 study: Lenvatinib plus pembrolizumab versus lenvatinib as first-line (1L) therapy for advanced hepatocellular carcinoma (aHCC)

P. Galle, Ruifeng Xu, J. Llovet, 2022, Annals of Oncology.

A phase Ib trial of lenvatinib (LEN) plus pembrolizumab (PEMBRO) in unresectable hepatocellular carcinoma (uHCC): Updated results

M. Kudo, S. Kaneko, J. Llovet, 2019, Annals of Oncology.

SUCCESSFUL HEMOSTASIS WITH OCTREOTIDE FOR BLEEDING FROM ULCERS DEVELOPING AFTER ENDOSCOPIC VARICEAL LIGATION ; REPORT OF TWO CASES

K. Chayama, M. Kobayashi, K. Ikeda, 1997 .